UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (477) 477
Newspaper Article (27) 27
Newsletter (23) 23
Magazine Article (7) 7
Book Chapter (6) 6
Conference Proceeding (1) 1
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
saxagliptin (524) 524
science & technology (286) 286
life sciences & biomedicine (271) 271
type 2 diabetes (221) 221
humans (193) 193
diabetes (159) 159
adamantane - analogs & derivatives (155) 155
diabetes mellitus, type 2 - drug therapy (147) 147
sitagliptin (139) 139
pharmacology & pharmacy (106) 106
male (100) 100
dipeptidyl-peptidase iv inhibitors - therapeutic use (97) 97
endocrinology & metabolism (91) 91
adamantane - therapeutic use (85) 85
dipeptides - therapeutic use (85) 85
female (85) 85
drug therapy (84) 84
vildagliptin (82) 82
research (78) 78
metformin (77) 77
hypoglycemic agents - therapeutic use (76) 76
adamantane - adverse effects (71) 71
dipeptides - adverse effects (70) 70
diabetes therapy (69) 69
dipeptidyl-peptidase iv inhibitors - adverse effects (68) 68
middle aged (68) 68
diabetes mellitus (67) 67
dosage and administration (67) 67
linagliptin (67) 67
treatment outcome (67) 67
type 2 diabetes mellitus (66) 66
dapagliflozin (64) 64
hypoglycemic agents - adverse effects (58) 58
alogliptin (57) 57
care and treatment (56) 56
aged (54) 54
glucose (54) 54
drug therapy, combination (53) 53
analysis (52) 52
adult (49) 49
animals (49) 49
internal medicine (48) 48
risk factors (47) 47
clinical trials (46) 46
adamantane - administration & dosage (45) 45
dipeptides - administration & dosage (44) 44
hypoglycemic agents (43) 43
diabetes mellitus, type 2 - blood (39) 39
dpp-4 inhibitors (39) 39
hypoglycemic agents - administration & dosage (38) 38
dpp-4 inhibitor (37) 37
liraglutide (37) 37
medicine & public health (37) 37
pharmaceutical industry (37) 37
blood glucose - drug effects (36) 36
dipeptidyl-peptidase iv inhibitors - administration & dosage (36) 36
hypoglycemia (36) 36
dipeptidyl-peptidase iv inhibitors - pharmacology (35) 35
double-blind method (35) 35
complications and side effects (32) 32
heart failure (32) 32
biological and medical sciences (31) 31
diabetes mellitus, type 2 - complications (31) 31
insulin (31) 31
medical sciences (31) 31
physical fitness (31) 31
adamantane - pharmacology (30) 30
blood glucose - metabolism (30) 30
dipeptides - pharmacology (30) 30
general & internal medicine (30) 30
medicine, general & internal (30) 30
metformin - therapeutic use (30) 30
patients (30) 30
dipeptidyl peptidase-4 inhibitor (29) 29
exenatide (29) 29
incretin (29) 29
glycosylated hemoglobin (27) 27
dipeptidyl peptidase-4 inhibitors (26) 26
endocrine system diseases (26) 26
glucagon (26) 26
glycated hemoglobin a - metabolism (26) 26
health aspects (26) 26
peptidase (26) 26
medical research (25) 25
medicine (25) 25
adamantane - pharmacokinetics (24) 24
dextrose (24) 24
metformin - administration & dosage (24) 24
review (24) 24
diabetes. impaired glucose tolerance (23) 23
endocrine pancreas. apud cells (23) 23
endocrinopathies (23) 23
pharmacology (23) 23
studies (23) 23
cardiology (22) 22
cardiovascular system & cardiology (22) 22
dipeptides - pharmacokinetics (22) 22
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (22) 22
endocrinology (22) 22
etiopathogenesis. screening. investigations. target tissue resistance (22) 22
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (528) 528
French (4) 4
Portuguese (4) 4
Japanese (3) 3
Russian (3) 3
Czech (2) 2
Hungarian (2) 2
Spanish (2) 2
Chinese (1) 1
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Process biochemistry (1991), ISSN 1359-5113, 02/2018, Volume 65, p. 109
Journal Article
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, ISSN 1386-1425, 11/2020, Volume 241, p. 118638
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2018, Volume 321, Issue 1, pp. 69 - 79
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Kidney Failure, Chronic - mortality | Cardiovascular Diseases - etiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Risk Factors | Linagliptin - adverse effects | Proportional Hazards Models | Male | Linagliptin - therapeutic use | Glycated Hemoglobin A | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Hypoglycemia - chemically induced | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - etiology | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Vascular diseases | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Index Medicus | Abridged Index Medicus | Online First | Original Investigation
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 09/2018, Volume 503, Issue 3, p. 1618
Journal Article
Journal Article
ACS catalysis, ISSN 2155-5435, 03/2019, Volume 9, Issue 3, pp. 2292 - 2302
Journal Article